Improved Case of Bronchial Asthma by Re-administration of Pranlukast from Montelukast: Evaluation of Eosinophilic Inflammation in the Peripheral Airway
Background: Pranlukast and Montelukast are Cysteinyl leukotriene receptor antagonists with almost the same pharmacological activity. However, I will describe a case in which these drugs showed different therapeutic effects on clinical symptoms during the daytime and eosinophilic inflammation in the...
Main Author: | Hiroyuki Ohbayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015310832 |
Similar Items
-
Population pharmacokinetics of pranlukast hydrate dry syrup in children with bronchial asthma
by: Ryosuke Inoue, et al.
Published: (2003-01-01) -
Hydrofluoroalkane-Beclomethasone Dipropionate Effectively Improves Airway Eosinophilic Inflammation Including the Distal Airways of Patients with Mild to Moderate Persistent Asthma as Compared with Fluticasone Propionate in a Randomized Open Double-Cross Study
by: Hiroyuki Ohbayashi, et al.
Published: (2008-01-01) -
Population-based open-label clinical effectiveness assessment of the cysteinyl leukotriene receptor antagonist pranlukast
by: Gen Tamura, et al.
Published: (2000-01-01) -
The role of the eosinophil-selective chemokine, eotaxin, in allergic and non-allergic airways inflammation
by: Dolores M Conroy, et al.
Published: (1997-12-01) -
Eotaxin and the attraction of eosinophils to the asthmatic lung
by: Williams Timothy J, et al.
Published: (2001-03-01)